Helicobacter pylori infection in gastroesophageal reflux disease in the Asian countries

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Hong, Su Jin ^a   Kim, Sang Woo ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ACHLORHYDRIA; ASIA; BACTERIAL VIRULENCE; DISEASE EXACERBATION; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HEREDITY; HUMAN; INCIDENCE; NONHUMAN; PREVALENCE; REVIEW; STOMACH ACID; STOMACH ACID SECRETION; STOMACH PH; STOMACH SECRETION;

EID: 84921449626     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/985249     Document Type: Review

References (58)

1. G. R. Locke III, N. J. Talley, S. L. Fett, A. R. Zinsmeister, and L. J. Melton III, and quot;Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota, and " Gastroenterology, vol. 112, no. 5, pp. 1448-1456, 1997.
2. J. Y. Kang, and quot;Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease, and " Alimentary Pharmacology and Therapeutics, vol. 20, no. 7, pp. 705-717, 2004.
3. J. Dent, H. B. El-Serag, M.-A. Wallander, and S. Johansson, and quot;Epidemiology of gastro-oesophageal reflux disease: a systematic review, and " Gut, vol. 54, no. 5, pp. 710-717, 2005.
4. A. Becher and J. Dent, and quot;Systematic review: ageing and gastrooesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis, and quot;Alimentary Pharmacology&Therapeutics, vol. 33, no. 4, pp. 442-454, 2011.
5. N. Kim, S. W. Lee, S. I. Cho et al., and quot;The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwidemulticentre prospective study in Korea, and " Alimentary Pharmacology and Therapeutics, vol. 27, no. 2, pp. 173-185, 2008.
6. W. M. Wong, K. C. Lai, K. F. Lam et al., and quot;Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study, and " Alimentary Pharmacology and Therapeutics, vol. 18, no. 6, pp. 595-604, 2003.
7. D. A. Corley, A. Kubo, T. R. Levin et al., and quot;Helicobacter pylori and gastroesophageal reflux disease: a case-control study, and " Helicobacter, vol. 13, no. 5, pp. 352-360, 2008.
8. K. Y. Ho, Y. H. Chan, and J. Y. Kang, and quot;Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country, and " The American Journal of Gastroenterology, vol. 100, no. 9, pp. 1923-1928, 2005.
9. W. G. Shin, H. U. Kim, S. G. Kim et al., and quot;Work productivity and activity impairment in gastroesophageal reflux disease in Korean full-time employees: a multicentre study, and " Digestive and Liver Disease, vol. 44, no. 4, pp. 286-291, 2012.
10. E. M. M. Quigley and A. P. S. Hungin, and quot;Review article: qualityof-life issues in gastro-oesophageal reflux disease, and " Alimentary Pharmacology and Therapeutics, vol. 22, supplement 1, pp. 41-47, 2005.
11. B. B. Dean, J. A. Crawley, C. M. Schmitt, J. Wong, and J. J. Ofman, and quot;The burden of illness of gastro-oesophageal reflux disease: impact on work productivity, and " Alimentary Pharmacology and Therapeutics, vol. 17, no. 10, pp. 1309-1317, 2003.
12. K. E. L. McColl, E. El-Omar, and D. Gillen, and quot;Interactions between H. pylori infection, gastric acid secretion and antisecretory therapy, and " British Medical Bulletin, vol. 54, no. 1, pp. 121-138, 1998.
13. T. Koike, S. Ohara, H. Sekine et al., and quot;Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis, and " American Journal of Gastroenterology, vol. 94, no. 12, pp. 3468-3472, 1999.
14. T. Koike, S. Ohara, H. Sekine et al., and quot;Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion, and " Gut, vol. 49, no. 3, pp. 330-334, 2001.
15. T. Azuma, S. Yamazaki, A. Yamakawa et al., and quot;Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer, and " Journal of Infectious Diseases, vol. 189, no. 5, pp. 820-827, 2004.
16. T. Ando, E. M. El-Omar, Y. Goto et al., and quot;Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy, and " Gut, vol. 55, no. 2, pp. 158-164, 2006.
17. S. Kato, M. Onda, S. Yamada, N. Matsuda, A. Tokunaga, and N. Matsukura, and quot;Association of the interleukin-1 genetic polymorphism and gastric cancer risk in Japanese, and " Journal of Gastroenterology, vol. 36, no. 10, pp. 696-699, 2001.
18. T. Furuta, E. M. El-Omar, F. Xiao, N. Shirai, M. Takashima, and H. Sugimura, and quot;Interleukin 1 polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan, and " Gastroenterology, vol. 123, pp. 92-105, 2002.
19. D. M. M. Queiroz, J. B. Guerra, G. A. Rocha et al., and quot;IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis, and " Gastroenterology, vol. 127, no. 1, pp. 73-79, 2004.
20. D. Chourasia, B. R. Achyut, S. Tripathi, B. Mittal, R. D. Mittal, and U. C. Ghoshal, and quot;Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511T/IL-1RN1 (T1) haplotype may protect against the disease, and " The American Journal of Gastroenterology, vol. 104, no. 11, pp. 2704-2713, 2009.
21. J. J. Kim, N. Kim, S. Hwang et al., and quot;Relationship of interleukin-1 levels and gastroesophageal reflux disease in Korea, and " Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 90-98, 2013.
22. A. Muramatsu, T. Azuma, T. Okuda et al., and quot;Association between interleukin-1-511C/T polymorphism and reflux esophagitis in Japan, and " Journal of Gastroenterology, vol. 40, no. 9, pp. 873-877, 2005.
23. D. R. de Vries, J. J. M. Ter Linde, M. A. van Herwaarden, A. J. P. M. Smout, and M. Samsom, and quot;Gastroesophageal reflux disease is associated with the C825T polymorphism in the Gprotein beta3 subunit gene (GNB3), and " The American Journal of Gastroenterology, vol. 104, no. 2, pp. 281-285, 2009.
24. M. D. Gough, R. Ackroyd, A. W. Majeed, and N. C. Bird, and quot;Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?" The American Journal of Gastroenterology, vol. 100, no. 5, pp. 1012-1018, 2005.
25. M. Kawamura, S. Ohara, T. Koike et al., and quot;The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism, and " Alimentary Pharmacology and Therapeutics, vol. 17, no. 7, pp. 965-973, 2003.
26. A. G. Casson, Z. Zheng, G. A. Porter, and D. L. Guernsey, and quot;Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma, and " Cancer Detection and Prevention, vol. 30, no. 5, pp. 423-431, 2006.
27. B. Liu, Y. J. Fan, M. L. Wang et al., and quot;Genetic polymorphisms in glutathione S-transferases T1, M1 and P1 and susceptibility to reflux esophagitis, and " Diseases of the Esophagus, vol. 19, no. 6, pp. 477-481, 2006.
28. A. G. Casson, Z. Zheng, S. C. Evans et al., and quot;Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma, and " Cancer, vol. 104, no. 4, pp. 730-739, 2005.
29. A. G. Casson, Z. Zheng, S. C. Evans, P. J. Veugelers, G. A. Porter, and D. L. Guernsey, and quot;Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma, and " Carcinogenesis, vol. 26, no. 9, pp. 1536-1541, 2005.
30. S. J. Chung, S. H. Lim, J. Choi et al., and quot;Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched casecontrol study of 5, 616 health check-up Koreans, and " Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 267-273, 2011.
31. T. Gunji, H. Sato, K. Iijima et al., and quot;Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males, and " Journal of Gastroenterology, vol. 46, no. 4, pp. 448-455, 2011.
32. H. Chiba, T. Gunji, H. Sato et al., and quot;A cross-sectional study on the risk factors for erosive esophagitis in young adults, and " Internal Medicine, vol. 51, no. 11, pp. 1293-1299, 2012.
33. H. Ashktorab, O. Entezari, M. Nouraie et al., and quot;Helicobacter pylori protection against reflux esophagitis, and " Digestive Diseases and Sciences, vol. 57, no. 11, pp. 2924-2928, 2012.
34. A. Sonnenberg, R. H. Lash, and R. M. Genta, and quot;A national study of helicobactor pylori infection in gastric biopsy specimens, and " Gastroenterology, vol. 139, no. 6, pp. 1894. e2-1901. e2, 2010.
35. A. P. Thrift, N. Pandeya, K. J. Smith et al., and quot;Helicobacter pylori infection and the risks of Barretts oesophagus: a populationbased case-control study, and " International Journal of Cancer, vol. 130, no. 10, pp. 2407-2416, 2012.
36. J. J. Vicari, R. M. Peek, G. W. Falk et al., and quot;The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease, and " Gastroenterology, vol. 115, no. 1, pp. 50-57, 1998.
37. A. P. Weston, A. S. Badr, M. Topalovski, R. Cherian, A. Dixon, and R. S. Hassanein, and quot;Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barretts esophagus, Barretts dysplasia, and Barretts adenocarcinoma, and " American Journal of Gastroenterology, vol. 95, no. 2, pp. 387-394, 2000.
38. J. Zhang, X.-L. Chen, K.-M. Wang, X.-D. Guo, A.-L. Zuo, and J. Gong, and quot;Relationship of gastric Helicobacter pylori infection to Barretts esophagus and gastro-esophageal reflux disease in Chinese, and " World Journal of Gastroenterology, vol. 10, no. 5, pp. 672-675, 2004.
39. Y. Abe, S. Ohara, T. Koike et al., and quot;The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barretts esophagus in Japan, and " The American Journal of Gastroenterology, vol. 99, no. 7, pp. 1213-1221, 2004.
40. T. Rokkas, D. Pistiolas, P. Sechopoulos, I. Robotis, and G. Margantinis, and quot;Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis, and " Clinical Gastroenterology and Hepatology, vol. 5, no. 12, pp. 1413-1417, 2007.
41. D. C. Whiteman, P. Parmar, P. Fahey et al., and quot;Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers, and " Gastroenterology, vol. 139, no. 1, pp. 73-83, 2010.
42. T. Xie, X. Cui, H. Zheng, D. Chen, L. He, and B. Jiang, and quot;Metaanalysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease, and " European Journal of Gastroenterology and Hepatology, vol. 25, no. 10, pp. 1195-1205, 2013.
43. M. Yaghoobi, F. Farrokhyar, Y. Yuan, and R. H. Hunt, and quot;Is there an increased risk of GERD after Helicobacter pylori eradication: ameta-analysis, and quot;The American Journal of Gastroenterology, vol. 105, no. 5, pp. 1007-1013, 2010.
44. B. Qian, S. Ma, L. Shang, J. Qian, and G. Zhang, and quot;Effects of Helicobacter pylori eradication on gastroesophageal reflux disease, and " Helicobacter, vol. 16, no. 4, pp. 255-265, 2011.
45. A. M. Saad, A. Choudhary, and M. L. Bechtold, and quot;Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials, and " Scandinavian Journal of Gastroenterology, vol. 47, no. 2, pp. 129-135, 2012.
46. A. E. Berstad, J. G. Hatlebakk, H. Maartmann-Moe, and P. Brandtzaeg, and quot;Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole, and " Gut, vol. 41, no. 6, pp. 740-747, 1997.
47. P. Moayyedi, C. Wason, R. Peacock et al., and quot;Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression, and " Helicobacter, vol. 5, no. 4, pp. 206-214, 2000.
48. S. Gudlaugsdottir, H. Van Dekken, T. Stijnen, and J. H. P. Wilson, and quot;Prolonged use of proton pump inhibitors, CagAstatus, and the outcome of Helicobacter pylori gastritis, and " Journal of Clinical Gastroenterology, vol. 34, no. 5, pp. 536-540, 2002.
49. K. M. Fock, P. Katelaris, K. Sugano et al., and quot;Second Asia-Pacific consensus guidelines for Helicobacter pylori infection, and " Journal of Gastroenterology and Hepatology, vol. 24, no. 10, pp. 1587-1600, 2009.
50. T. Koike, S. Ohara, H. Sekine et al., and quot;Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis, and " Alimentary Pharmacology and Therapeutics, vol. 15, no. 6, pp. 813-820, 2001.
51. H. Hamada, K. Haruma, M. Mihara et al., and quot;High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis, and " Alimentary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 729-735, 2000.
52. T. Rokkas, S. D. Ladas, K. Triantafyllou et al., and quot;The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori, and " The American Journal of Medicine, vol. 110, no. 9, pp. 703-707, 2001.
53. P. Malfertheiner, J. Dent, L. Zeijlon et al., and quot;Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease-results from a randomized trial programme, and " Alimentary Pharmacology and Therapeutics, vol. 16, no. 8, pp. 1431-1442, 2002.
54. N. Vakil, N. J. Talley, M. Stolte, M. Sundin, O. Junghard, and E. Bolling-Sternevald, and quot;Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease inWestern patients with non-ulcer dyspepsia, and " Alimentary Pharmacology and Therapeutics, vol. 24, no. 1, pp. 55-63, 2006.
55. P. Malfertheiner, F. Megraud, C. A. OMorain et al., and quot;Management of Helicobacter pylori infection-the Maastricht IV/ Florence consensus report, and " Gut, vol. 61, no. 5, pp. 646-664, 2012.
56. S. Y. Nam, I. J. Choi, K. H. Ryu, B. C. Kim, C. G. Kim, and B.-H. Nam, and quot;Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms, and " The American Journal of Gastroenterology, vol. 105, no. 10, pp. 2153-2162, 2010.
57. N. Kim, S. W. Lee, J. I. Kim et al., and quot;Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study, and " Gut and Liver, vol. 5, no. 4, pp. 437-446, 2011.
58. S. G. Kim, H. Jung, H. L. Lee et al., and quot;Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition, and " Journal of Gastroenterology and Hepatology, vol. 29, pp. 1371-1386, 2014.